http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0826686-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-16 |
| filingDate | 1997-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26506fcadaab848710cf3cda565bc9b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9037d03b1fd3b7eeda4aebb973c21d0e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cfe63601d74bad7cabd11271e1343cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86d3ed42917cc399ffcd67f32b572fa4 |
| publicationDate | 1998-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0826686-A2 |
| titleOfInvention | Tricyclic compounds, their production and use |
| abstract | A pharmaceutical composition for treating ornpreventing proliferative glomerulonephritis, whichncomprises a compound of the formula:n n wherein ring A is a nitrogen-containing heterocyclicnring, having two nitrogen atoms as the hetero-atoms,nwhich may be substituted with oxo or thioxo; ring Q maynbe substituted; Y is an optionally substitutednhydrocarbon group, an optionally substituted hydroxyngroup or an optionally substituted mercapto group; and R 1 is a hydrogen atom, a halogen atom, an optionallynsubstituted hydrocarbon group or an acyl group, or ansalt thereof, and a novel compound of the formula:n wherein ring A a may have one oxo group; D is a bond ornan optionally substituted divalent hydrocarbon group; ring W is an optionally substituted nitrogen-containingnheterocyclic ring; ring Q may be substituted; and R 3 isnan electron-withdrawing group, or a salt thereof,nwhich have excellent PDGF-inhibiting activities,nactivities of ameliorating renal diseases andnactivities of lowering lipid level and are less toxicnand are useful as a preventive and treating agent forncardisvascular diseases. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8362030-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7087608-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0164200-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0164200-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9847901-A1 |
| priorityDate | 1996-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 864.